EA201600469A1 - Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости - Google Patents
Фармацевтический препарат для профилактики и лечения прогрессирующей близорукостиInfo
- Publication number
- EA201600469A1 EA201600469A1 EA201600469A EA201600469A EA201600469A1 EA 201600469 A1 EA201600469 A1 EA 201600469A1 EA 201600469 A EA201600469 A EA 201600469A EA 201600469 A EA201600469 A EA 201600469A EA 201600469 A1 EA201600469 A1 EA 201600469A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- prevention
- progressive myopia
- pharmaceutical preparation
- sclera
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 230000000750 progressive effect Effects 0.000 title 1
- 208000001309 degenerative myopia Diseases 0.000 abstract 3
- 230000004515 progressive myopia Effects 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 210000001508 eye Anatomy 0.000 abstract 2
- 210000003786 sclera Anatomy 0.000 abstract 2
- 238000005728 strengthening Methods 0.000 abstract 2
- 150000001412 amines Chemical class 0.000 abstract 1
- 210000005252 bulbus oculi Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 229910052723 transition metal Inorganic materials 0.000 abstract 1
- 150000003624 transition metals Chemical class 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Изобретение относится к медицине, в частности к офтальмологии, и предназначено для укрепления склеры в целях профилактики и лечения прогрессирующей близорукости. Изобретение направлено на укрепление склеры при прогрессирующей миопии и снижение сроков такого укрепления, исключение травмирующих, токсических и воспалительных действий на глазное яблоко и окружающие его ткани орбиты при лечении прогрессирующей близорукости. Поставленные задачи достигаются за счет создания и применения фармацевтического препарата, представляющего собой водный раствор для инстилляций, или глазной гель, или глазную лекарственную пленку, содержащего в своем составе эффективное количество амина с функциональными группами в виде соли или в составе комплексного соединения переходного металла или их смеси.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013155972A RU2635185C2 (ru) | 2013-12-17 | 2013-12-17 | Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости |
PCT/RU2014/000949 WO2015094019A2 (ru) | 2013-12-17 | 2014-12-16 | Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201600469A1 true EA201600469A1 (ru) | 2016-10-31 |
EA037996B1 EA037996B1 (ru) | 2021-06-21 |
Family
ID=53403853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201600469A EA037996B1 (ru) | 2013-12-17 | 2014-12-16 | Применение композиции на основе первичного амина с функциональными группами в качестве склероукрепляющего агента |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3103446B1 (ru) |
CN (1) | CN106132402A (ru) |
EA (1) | EA037996B1 (ru) |
IL (1) | IL246286B (ru) |
RU (1) | RU2635185C2 (ru) |
WO (1) | WO2015094019A2 (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5753957B2 (ja) * | 2013-01-31 | 2015-07-22 | 千寿製薬株式会社 | 安定な水性液剤 |
WO2017219080A1 (en) * | 2016-06-21 | 2017-12-28 | The University Of Newcastle | Treatment for myopia |
US11524032B2 (en) | 2018-01-05 | 2022-12-13 | University Of Utah Research Foundation | Treatment of myopic progression |
WO2020015377A1 (zh) * | 2018-07-18 | 2020-01-23 | 温州医科大学 | 一种治疗近视的方法及制备药物的应用 |
WO2023098537A1 (zh) * | 2021-12-01 | 2023-06-08 | 盛元医药广州有限公司 | 丙谷二肽的新用途和包含丙谷二肽的眼用组合物 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4248855A (en) * | 1976-08-27 | 1981-02-03 | Hydrophilics International, Inc. | Pharmaceutical base salts |
IT1197289B (it) * | 1986-09-26 | 1988-11-30 | S I F I Societa Ind Farmaceuti | Sale di lisina dell'acido 4-bifenilacetico e sue composizioni oftalmiche |
RU2012336C1 (ru) * | 1987-12-23 | 1994-05-15 | Московский научно-исследовательский институт глазных болезней им.Гельмгольца | Состав для лечения прогрессирующей близорукости |
JPH04502012A (ja) * | 1989-09-27 | 1992-04-09 | モスコフスキ ナウチノ―イススレドバテルスキ インスティテュト グラツィニフ ボレツネイ イメニ ゲルムゴルツァ | 進行性近視の治療用組成物 |
WO2002024191A1 (fr) * | 2000-09-20 | 2002-03-28 | Yong Guang Pharmaceutical Co., Ltd. | Medicament permettant de traiter et de prevenir la myopie |
US6540990B2 (en) * | 2000-09-22 | 2003-04-01 | Gerard M. Nolan | Physiological method of improving vision |
US8557868B2 (en) * | 2000-11-04 | 2013-10-15 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions using low molecular weight amines |
RU2192261C2 (ru) * | 2000-11-20 | 2002-11-10 | Московский научно-исследовательский институт глазных болезней им.Гельмгольца | Средство консервативного лечения прогрессирующей и осложненной близорукости |
NZ529615A (en) * | 2001-05-25 | 2005-07-29 | Valley Forge Pharmaceuticals | Pirenzepine ophthalmic gel |
US20030087830A1 (en) * | 2001-06-12 | 2003-05-08 | Eric Dupont | Low molecular weight components of cartilage, complexes of metals with amino acids, DI-peptides and analogs thereof; processes for preparation and therapeutic uses thereof |
AU2003208833A1 (en) * | 2002-02-14 | 2003-09-04 | Merck Patent Gmbh | Methods and compositions for the treatment of eye diseases |
US20060166879A1 (en) * | 2002-12-20 | 2006-07-27 | Chakshu Research Inc | Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders |
CA2468664C (en) * | 2003-06-03 | 2012-03-06 | Allergan, Inc. | Ketorolac tromethamine compositions for treating or preventing ocular pain |
AU2005309555A1 (en) * | 2004-11-23 | 2006-06-01 | Alcon, Inc. | Triple natural polymer viscoelastic composition |
CN100391475C (zh) * | 2005-09-29 | 2008-06-04 | 李广中 | 一种紫睛制剂眼素肽注射液及其在制备治疗近视眼药物中的应用 |
EP2319539A4 (en) * | 2008-07-24 | 2012-03-28 | Univ Osaka | PROPHYLACTIC OR THERAPEUTIC AGENT FOR AXIAL MYOPIA |
AU2012298156B2 (en) * | 2011-08-23 | 2017-08-17 | Yeda Research And Development Co.Ltd. | Method for photodynamic therapy of corneal thinning or scleral weakening with bacteriochlorophyll compounds |
US20140322193A1 (en) * | 2011-12-02 | 2014-10-30 | Michael Kaleko | Therapies for Disorders of the Cornea and Conjunctiva |
-
2013
- 2013-12-17 RU RU2013155972A patent/RU2635185C2/ru not_active IP Right Cessation
-
2014
- 2014-12-16 EA EA201600469A patent/EA037996B1/ru unknown
- 2014-12-16 WO PCT/RU2014/000949 patent/WO2015094019A2/ru active Application Filing
- 2014-12-16 CN CN201480075649.8A patent/CN106132402A/zh active Pending
- 2014-12-16 EP EP14872234.1A patent/EP3103446B1/en active Active
-
2016
- 2016-06-16 IL IL246286A patent/IL246286B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2015094019A2 (ru) | 2015-06-25 |
CN106132402A (zh) | 2016-11-16 |
RU2013155972A (ru) | 2015-06-27 |
IL246286A0 (en) | 2016-07-31 |
EP3103446A2 (en) | 2016-12-14 |
EA037996B1 (ru) | 2021-06-21 |
WO2015094019A3 (ru) | 2015-08-20 |
IL246286B (en) | 2021-12-01 |
EP3103446B1 (en) | 2024-02-14 |
EP3103446A4 (en) | 2017-10-18 |
RU2635185C2 (ru) | 2017-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201600469A1 (ru) | Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости | |
EA201792559A1 (ru) | Фармацевтические композиции для местного применения | |
BR112014008789A2 (pt) | prevenção e tratamento de condições oculares | |
CY1121698T1 (el) | Υγρο σκευασμα για εισπνοη που περιεχει rpl554 | |
PH12019501902A1 (en) | Ocular formulations for drug-delivery to the posterior segment of the eye | |
MY180145A (en) | Cenicriviroc compositions and methods of making and using the same | |
MX2023003124A (es) | Composiciones farmaceuticas oftalmicas y usos que se relacionan a las mismas. | |
BR112015019039A2 (pt) | antagonistas de integrina fluorados | |
PH12020550452A1 (en) | New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (pf-ild) | |
EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
RU2019139886A (ru) | Терапевтическое средство против дисфункции мейбомиевых желез | |
AR106364A1 (es) | Derivados de insulina y sus usos médicos | |
MD3359146T2 (ro) | Compoziții farmaceutice și utilizări direcționate spre bolile de depozitare lizozomală | |
EA202191684A1 (ru) | Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии | |
CY1124538T1 (el) | Χρηση prg4 για τη βελτιωση της δυναμικης οπτικης οξυτητας και εκτροπων υψηλοτερης ταξης | |
EA201490516A1 (ru) | Бифенилкарбоксиамиды в качестве ингибиторов rock-киназ | |
EA201990752A1 (ru) | Офтальмологический состав, содержащий цитиколин, переносимый липосомой, для лечения глаукомы | |
EA201691656A2 (ru) | Терапевтические способы с применением норибогаина и родственных соединений | |
EA201591653A1 (ru) | Композиции для лечения глазных расстройств с применением дипиридамола | |
PH12020550722A1 (en) | Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye | |
MX2020012011A (es) | Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular. | |
EA202091139A1 (ru) | Производные имидазопиридина и их применение в качестве лекарственного средства | |
EA200970562A1 (ru) | Применение l-карнитина для получения лекарственного средства в форме глазных капель для лечения заболеваний роговицы | |
MX2018004779A (es) | Uso terapeutico de una solucion oftalmica acuosa esteril. | |
EA201990550A1 (ru) | Офтальмологический препарат, включающий азоловое соединение |